Variant report

Variant	esv3322868
Chromosome Location	chr2:173291131-173293679
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:605)
CpG islands
(count:1038)
Chromatin interactive
region (count:5)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:605 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:173292090-173292504	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:173293139-173293530	HepG2	liver:	n/a	n/a
3	ATF2	chr2:173291667-173292184	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr2:173292974-173293425	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr2:173291931-173292473	H1-hESC	embryonic stem cell:	n/a	n/a
6	BHLHE40	chr2:173292946-173293146	A549	lung:	n/a	n/a
7	BHLHE40	chr2:173291690-173293224	HepG2	liver:	n/a	chr2:173292390-173292406 chr2:173292470-173292486
8	BRCA1	chr2:173292047-173292183	HepG2	liver:	n/a	n/a
9	BRCA1	chr2:173292581-173292602	H1-hESC	embryonic stem cell:	n/a	n/a
10	BRCA1	chr2:173291827-173292596	Hela-S3	cervix:	n/a	n/a
11	CCNT2	chr2:173292200-173292608	K562	blood:	n/a	chr2:173292384-173292393 chr2:173292257-173292266
12	CEBPB	chr2:173291943-173292442	Hela-S3	cervix:	n/a	n/a
13	CEBPD	chr2:173292103-173292480	HepG2	liver:	n/a	n/a
14	CEBPD	chr2:173292046-173292727	HepG2	liver:	n/a	n/a
15	CHD1	chr2:173292906-173293164	H1-hESC	embryonic stem cell:	n/a	n/a
16	CHD1	chr2:173293408-173293833	H1-hESC	embryonic stem cell:	n/a	n/a
17	CHD1	chr2:173292320-173292658	H1-hESC	embryonic stem cell:	n/a	n/a
18	CHD2	chr2:173292729-173292733	HepG2	liver:	n/a	n/a
19	CHD2	chr2:173292231-173292515	HepG2	liver:	n/a	n/a
20	CHD2	chr2:173292186-173292338	H1-hESC	embryonic stem cell:	n/a	n/a
21	CHD2	chr2:173291973-173293551	Hela-S3	cervix:	n/a	n/a
22	CHD2	chr2:173292952-173293703	H1-hESC	embryonic stem cell:	n/a	n/a
23	CHD2	chr2:173293198-173293538	HepG2	liver:	n/a	n/a
24	CREB1	chr2:173291720-173293971	HepG2	liver:	n/a	n/a
25	CREB1	chr2:173291890-173292778	A549	lung:	n/a	n/a
26	CTCF	chr2:173291980-173292130	AG04449	skin:	n/a	n/a
27	CTCF	chr2:173292106-173292117	GM12892	blood:	n/a	n/a
28	CTCF	chr2:173292920-173293070	HCT-116	colon:	n/a	n/a
29	CTCF	chr2:173292240-173292390	GM12864	blood:	n/a	chr2:173292343-173292356
30	CTCF	chr2:173292920-173293070	RPTEC	kidney:	n/a	n/a
31	CTCF	chr2:173291980-173292130	AoAF	blood vessel:	n/a	n/a
32	CTCF	chr2:173292240-173292390	GM12868	blood:	n/a	chr2:173292343-173292356
33	CTCF	chr2:173292280-173292430	AoAF	blood vessel:	n/a	chr2:173292343-173292356
34	CTCF	chr2:173292983-173293037	GM10266	blood:	n/a	n/a
35	CTCF	chr2:173292960-173293110	GM06990	blood:	n/a	n/a
36	CTCF	chr2:173292920-173293070	HepG2	liver:	n/a	n/a
37	CTCF	chr2:173293220-173293370	SK-N-SH_RA	brain:	n/a	n/a
38	CTCF	chr2:173292028-173292094	Gliobla	brain:	n/a	n/a
39	CTCF	chr2:173293040-173293190	BJ	skin:	n/a	n/a
40	CTCF	chr2:173292260-173292410	HPF	lung:	n/a	chr2:173292343-173292356
41	CTCF	chr2:173292127-173292512	K562	blood:	n/a	chr2:173292343-173292356 chr2:173292474-173292487
42	CTCF	chr2:173292280-173292430	HEK293	kidney:	n/a	chr2:173292343-173292356
43	CTCF	chr2:173292140-173292290	AG04450	lung:	n/a	n/a
44	CTCF	chr2:173292979-173293078	GM19240	blood:	n/a	n/a
45	CTCF	chr2:173292393-173292396	GM19240	blood:	n/a	n/a
46	CTCF	chr2:173292040-173292190	AG09319	gingival:	n/a	n/a
47	CTCF	chr2:173292220-173292370	WI-38	lung:	n/a	chr2:173292343-173292356
48	CTCF	chr2:173292920-173293070	AoAF	blood vessel:	n/a	n/a
49	CTCF	chr2:173292143-173292479	H1-hESC	embryonic stem cell:	n/a	chr2:173292343-173292356
50	CTCF	chr2:173292280-173292430	HA-sp	spinal cord:	n/a	chr2:173292343-173292356

(count:1038 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:173292636-173292686	AG09319	gingival:	n/a
2	chr2:173292636-173292686	AG09319	gingival:	n/a
3	chr2:173291908-173291958	PrEC	prostate:	n/a
4	chr2:173292579-173292629	MCF-7	breast:	n/a
5	chr2:173293182-173293232	SK-N-SH	brain:	n/a
6	chr2:173293627-173293677	RPTEC	kidney:	n/a
7	chr2:173292579-173292629	SK-N-SH	brain:	n/a
8	chr2:173292277-173292327	AG09319	gingival:	n/a
9	chr2:173292271-173292321	Hela-S3	cervix:	n/a
10	chr2:173293182-173293232	SKMC	muscle:	n/a
11	chr2:173292207-173292257	AG04450	lung:	fetal
12	chr2:173291965-173292015	LNCaP	prostate:	n/a
13	chr2:173292329-173292379	SK-N-SH_RA	brain:	n/a
14	chr2:173293182-173293232	HUVEC	blood vessel:	n/a
15	chr2:173292216-173292266	BE2_C	brain:	n/a
16	chr2:173293182-173293232	SK-N-SH_RA	brain:	n/a
17	chr2:173292268-173292318	BJ	skin:	n/a
18	chr2:173293182-173293232	NH-A	brain:	n/a
19	chr2:173293627-173293677	GM12892	blood:	n/a
20	chr2:173291908-173291958	NHBE	bronchial:	n/a
21	chr2:173292329-173292379	HCPEpiC	choroid plexus:	n/a
22	chr2:173291908-173291958	NT2-D1	testis:	n/a
23	chr2:173291965-173292015	Caco-2	colon:	n/a
24	chr2:173291965-173292015	Hela-S3	cervix:	n/a
25	chr2:173292268-173292318	HNPCEpiC	eye:	n/a
26	chr2:173292329-173292379	T-47D	breast:	n/a
27	chr2:173293392-173293442	GM12891	blood:	n/a
28	chr2:173291908-173291958	A549	lung:	n/a
29	chr2:173292271-173292321	GM19239	blood:	n/a
30	chr2:173293627-173293677	HRPEpiC	eye:	n/a
31	chr2:173292277-173292327	A549	lung:	n/a
32	chr2:173292010-173292060	NH-A	brain:	n/a
33	chr2:173293392-173293442	GM12892	blood:	n/a
34	chr2:173292579-173292629	HPAEpiC	pulmonary alveolar:	n/a
35	chr2:173293328-173293378	SK-N-SH	brain:	n/a
36	chr2:173292216-173292266	RPTEC	kidney:	n/a
37	chr2:173293328-173293378	PrEC	prostate:	n/a
38	chr2:173293182-173293232	SAEC	small airway:	n/a
39	chr2:173292271-173292321	T-47D	breast:	n/a
40	chr2:173292978-173293028	Hela-S3	cervix:	n/a
41	chr2:173292277-173292327	HRPEpiC	eye:	n/a
42	chr2:173291908-173291958	AG10803	skin:	n/a
43	chr2:173292579-173292629	HRCEpiC	kidney:	n/a
44	chr2:173291908-173291958	HCPEpiC	choroid plexus:	n/a
45	chr2:173292271-173292321	PANC-1	pancreas:	n/a
46	chr2:173292216-173292266	ECC-1	luminal epithelium:	n/a
47	chr2:173292216-173292266	HEEpiC	esophagus:	n/a
48	chr2:173291965-173292015	ECC-1	luminal epithelium:	n/a
49	chr2:173293182-173293232	IMR90	lung:	fetal
50	chr2:173292277-173292327	GM12878	blood:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:173290254..173291940-chr2:173293674..173296240,2	MCF-7	breast:
2	chr12:98897396..98898383-chr2:173292432..173293421,2	Hela-S3	cervix:
3	chr2:173292559..173293271-chr2:173319543..173320061,2	MCF-7	breast:
4	chr2:173292234..173292806-chr4:75230715..75231293,2	HCT-116	colon:
5	chr2:173290254..173291940-chr2:173293674..173296240,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DLX2-2	chr2:173292502-173292675	ENSG00000226963.1
2	lnc-DLX2-2	chr2:173292948-173293331	ENSG00000226963.1

No data

Variant related genes	Relation type
ITGA6	TF binding region
ENSG00000226963	TF binding region
ITGA6	CpG island
ENSG00000226963	CpG island
ENSG00000124882	chromatin interactions
ENSG00000245017	chromatin interactions

Extended variants
information (count: 113 )
Associated
traits (count: 43 )

Variant overlapped rSNPs/rCNVs (count:113 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs540016771	chr2:173291140-173291141	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs558736924	chr2:173291141-173291142	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs143457098	chr2:173291163-173291164	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs182133041	chr2:173291170-173291171	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs562135096	chr2:173291225-173291226	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs111718021	chr2:173291269-173291270	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs73023476	chr2:173291359-173291360	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs528682561	chr2:173291360-173291361	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs147265557	chr2:173291384-173291385	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs141686758	chr2:173291437-173291438	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs145860229	chr2:173291481-173291482	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs112436982	chr2:173291516-173291517	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs183610084	chr2:173291590-173291591	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs550543903	chr2:173291605-173291606	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs548433893	chr2:173291624-173291625	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs568445816	chr2:173291644-173291645	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs188293303	chr2:173291649-173291650	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs547321726	chr2:173291653-173291654	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs547783382	chr2:173291724-173291725	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs530525819	chr2:173291802-173291803	Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs79603749	chr2:173291833-173291834	Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs570278480	chr2:173291865-173291866	Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs181118073	chr2:173291874-173291875	Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs143968653	chr2:173291915-173291916	Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs73976793	chr2:173292035-173292036	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs556066382	chr2:173292122-173292123	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs139999485	chr2:173292123-173292124	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs547926969	chr2:173292131-173292132	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs149424078	chr2:173292141-173292142	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs185356186	chr2:173292157-173292158	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs372445648	chr2:173292199-173292200	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs62167766	chr2:173292213-173292214	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs376150429	chr2:173292233-173292234	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs201818324	chr2:173292271-173292272	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs545924680	chr2:173292273-173292274	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs564668995	chr2:173292277-173292278	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs201590863	chr2:173292287-173292288	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs531972975	chr2:173292295-173292296	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs550482326	chr2:173292314-173292315	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs562335726	chr2:173292316-173292317	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs529633700	chr2:173292330-173292331	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs570513719	chr2:173292340-173292341	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs188609652	chr2:173292347-173292348	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs566072397	chr2:173292349-173292350	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs144682022	chr2:173292379-173292380	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs551897893	chr2:173292381-173292382	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs373890886	chr2:173292395-173292396	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs148497864	chr2:173292438-173292439	Active TSS Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs555954686	chr2:173292472-173292473	Active TSS Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs144341070	chr2:173292503-173292504	Active TSS Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:43)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Glioblastoma	21080181	CNVD
small cell lung cancer	20016488	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Prostate cancer	16573809	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Donnai-Barrow syndrome	21085971	CNVD
Breast cancer	21045282	CNVD
Limb abnormalities	22140379	CNVD
Sudden cardiac death	19188705	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:449 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:173285200-173291800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
2	chr2:173285200-173291800	Enhancers	Fetal Thymus	thymus
3	chr2:173288400-173291800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
4	chr2:173289000-173291600	Weak transcription	Adipose Nuclei	Adipose
5	chr2:173289400-173291400	Weak transcription	NHEK	skin
6	chr2:173290200-173291400	Enhancers	Primary T helper cells PMA-I stimulated	--
7	chr2:173290200-173291400	Enhancers	Rectal Mucosa Donor 31	rectum
8	chr2:173290200-173291600	Enhancers	Breast Myoepithelial Primary Cells	Breast
9	chr2:173290200-173291600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
10	chr2:173290200-173291600	Enhancers	Primary T helper cells fromperipheralblood	blood
11	chr2:173290200-173291800	Enhancers	H1 Cell Line	embryonic stem cell
12	chr2:173290200-173291800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
13	chr2:173290200-173292000	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
14	chr2:173290400-173291400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
15	chr2:173290400-173291400	Enhancers	Primary T helper naive cells from peripheral blood	blood
16	chr2:173290400-173291400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr2:173290400-173291800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
18	chr2:173290600-173291200	Enhancers	HUES48 Cell Line	embryonic stem cell
19	chr2:173290600-173291400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
20	chr2:173290600-173291600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
21	chr2:173290600-173291600	Enhancers	Primary T cells from cord blood	blood
22	chr2:173290600-173291800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
23	chr2:173290600-173291800	Weak transcription	Psoas Muscle	Psoas
24	chr2:173290800-173291600	Enhancers	ES-I3 Cell Line	embryonic stem cell
25	chr2:173290800-173291600	Enhancers	Primary T killer memory cells from peripheral blood	blood
26	chr2:173290800-173291600	Enhancers	Thymus	Thymus
27	chr2:173290800-173291800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr2:173290800-173291800	Enhancers	Primary T cells fromperipheralblood	blood
29	chr2:173290800-173291800	Bivalent Enhancer	Fetal Muscle Leg	muscle
30	chr2:173291000-173291200	Enhancers	Rectal Mucosa Donor 29	rectum
31	chr2:173291000-173291400	Enhancers	HUES64 Cell Line	embryonic stem cell
32	chr2:173291000-173291600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
33	chr2:173291000-173291800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
34	chr2:173291200-173291400	Enhancers	Duodenum Mucosa	Duodenum
35	chr2:173291200-173291600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
36	chr2:173291200-173291600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
37	chr2:173291200-173292200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
38	chr2:173291400-173291600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr2:173291400-173291600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
40	chr2:173291400-173291600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
41	chr2:173291400-173291600	Bivalent Enhancer	Primary B cells from cord blood	blood
42	chr2:173291400-173291600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
43	chr2:173291400-173291600	Enhancers	Esophagus	oesophagus
44	chr2:173291400-173291600	Bivalent Enhancer	Fetal Intestine Large	intestine
45	chr2:173291400-173291600	Enhancers	Skeletal Muscle Female	skeletal muscle
46	chr2:173291400-173291600	Bivalent Enhancer	Small Intestine	intestine
47	chr2:173291400-173291600	Bivalent Enhancer	Dnd41	blood
48	chr2:173291400-173291600	Enhancers	Hela-S3	cervix
49	chr2:173291400-173291600	Enhancers	NHEK	skin
50	chr2:173291400-173291800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links